These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 411407)

  • 21. [Phagocytosis of Staphylococcus aureus and Pseudomonas aeruginosa by pulmonary macrophages and granulocytes].
    Hürter T
    Pneumologie; 1989 Mar; 43(3):147-58. PubMed ID: 2496407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Handling technic and study of the in vitro behavior of the human alveolar macrophage].
    Voisin C; Aerts C; Tonnel AB; Wattel F; Petitprez A; Plancke Y
    Lille Med; 1971 May; 16(5):701-9. PubMed ID: 5115340
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity.
    Cooper JA; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Jul; 134(1):108-14. PubMed ID: 3014931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil-induced lung protection and injury are dependent on the amount of Pseudomonas aeruginosa administered via airways in guinea pigs.
    Terashima T; Kanazawa M; Sayama K; Urano T; Sakamaki F; Nakamura H; Waki Y; Soejima K; Tasaka S; Ishizaka A
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2150-6. PubMed ID: 8520789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the immunization of animals with a live plague vaccine on the lysosome count in organ-specific macrophages].
    Kiseleva AK; Vasil'eva GI
    Tsitologiia; 1990; 32(5):504-8. PubMed ID: 2275021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog.
    Ozaki T; Maeda M; Hayashi H; Nakamura Y; Moriguchi H; Kamei T; Yasuoka S; Ogura T
    Am Rev Respir Dis; 1989 Dec; 140(6):1595-601. PubMed ID: 2513762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phagocytosis of Staphylococcus aureus and Pseudomonas aeruginosa by pulmonary neutrophilic granulocytes].
    Hürter T; Steppling H; Rumpelt HJ
    Pneumologie; 1990 Feb; 44 Suppl 1():524-5. PubMed ID: 2114638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of pulmonary macrophages to unilateral instillation of carbon.
    Bowden DH; Adamson IY
    Am J Pathol; 1984 May; 115(2):151-5. PubMed ID: 6720870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of helper T-lymphocytes in bronchoalveolar lavage for the evaluation of the activity of pulmonary sarcoidosis].
    Costabel U; Bross KJ; Fischer J; Guzman J; Matthys H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():574-7. PubMed ID: 6227882
    [No Abstract]   [Full Text] [Related]  

  • 30. Interference of Pseudomonas aeruginosa with immunospecific host defenses.
    Petit JC; Daguet GL
    Biomed Pharmacother; 1983; 37(9-10):422-8. PubMed ID: 6232960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Time course of airway hyperresponsiveness and polymorphonuclear leukocyte counts in bronchoalveolar lavage fluid following endotoxin inhalation].
    Mutoh T; Koyama S; Saitoh O; Kintaka M; Koyama S; Ohkuma A; Horie T; Okayasu M
    Arerugi; 1987 Feb; 36(2):93-100. PubMed ID: 3300604
    [No Abstract]   [Full Text] [Related]  

  • 32. Depression and delayed recovery of alveolar macrophage function during starvation and refeeding.
    Shennib H; Chiu RC; Mulder DS; Lough JO
    Surg Gynecol Obstet; 1984 Jun; 158(6):535-40. PubMed ID: 6427957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of slime on phagocytosis of Pseudomonas aeruginosa by human pulmonary alveolar macrophages].
    Nakayama K; Yasuoka S; Tsubura E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Nov; 21(11):1062-8. PubMed ID: 6429400
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.
    Balow JE; Hurley DL; Fauci AS
    J Clin Invest; 1975 Jul; 56(1):65-70. PubMed ID: 1095612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapulmonary chemotaxins in the normal and in the cyclophosphamide-treated host.
    Pennington JE; Cole FS; Boerth LW
    Am Rev Respir Dis; 1985 Jun; 131(6):845-9. PubMed ID: 4003935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T- and B-lymphocyte numbers in bronchoalveolar washings from patients with sarcoidosis].
    Averbakh MM; Moroz AM; Kolodiazhnaia NS; Romanov VV
    Klin Med (Mosk); 1986 Dec; 64(12):44-7. PubMed ID: 3494159
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of acute pulmonary inflammation in strain 2 and strain 13 guinea pigs.
    Newton-Nash DK; Pontzer CH; Kahn L; Garancis JC; Abramoff P
    Reg Immunol; 1988; 1(2):111-8. PubMed ID: 3275213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
    Mathieu LG; deRepentigny J; Gadbois T
    Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The alveolar macrophage; its rôle in defense of lung tissue against infection].
    Voisin C; Tonnel AB; Aerts C; Wattel F
    Bull Physiopathol Respir (Nancy); 1971; 7(4):775-808. PubMed ID: 5000195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.